Changeflow GovPing Healthcare & Life Sciences Observational TFESI Efficacy in Lumbar Radicula...
Routine Notice Added Final

Observational TFESI Efficacy in Lumbar Radicular Pain

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

NIH registered an observational study (NCT07538765) evaluating the effectiveness of transforaminal epidural steroid injections (TFESI) in patients aged 18 to 90 with radicular low back pain caused by lumbar disc herniation who did not improve with conservative treatment. The three-month study tracks pain reduction using the Visual Analog Scale and functional improvement using the Oswestry Disability Index. No compliance obligations or deadlines are created by this registry entry.

Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

NIH registered a retrospective observational study on ClinicalTrials.gov examining whether transforaminal epidural steroid injections (TFESI) can effectively reduce pain and improve physical function in patients with radicular low back pain caused by lumbar disc herniation. Participants aged 18 to 90 will be monitored for three months with pain and disability metrics. This is a registry entry reflecting an active research program; it creates no compliance obligations or deadlines.

Healthcare providers and clinical investigators may monitor this study for emerging evidence on TFESI efficacy relative to surgery, but no regulatory action is required based on this document alone. The study does not impose any obligations on manufacturers, providers, or patients.

Archived snapshot

Apr 20, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Efficacy of TFESI in Lumbar Radicular Pain

Observational NCT07538765 Kind: OBSERVATIONAL Apr 20, 2026

Abstract

The goal of this retrospective study is to evaluate the effectiveness of transforaminal epidural steroid injections (TFESI) in patients with radicular low back pain caused by lumbar disc herniation who did not improve with conservative treatment.

The main questions it aims to answer are:

How effective is TFESI in reducing pain and improving physical function over a three-month period?

Can this procedure serve as a viable alternative to surgery for patients with persistent radiculopathy?

Participants aged 18 to 90 underwent image-guided injections and were monitored for three months. Researchers tracked changes in their pain levels (using the Visual Analog Scale) and their ability to perform daily activities (using the Oswestry Disability Index) to determine the treatment's success.

Conditions: Transforaminal Epidural Steroid Injection, Radicular Low Back Pain

Interventions: transforaminal epidural steroid injections (TFESI)

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 20th, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Healthcare providers Clinical investigators Patients
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Medical research
Geographic scope
United States US

Taxonomy

Primary area
Public Health
Operational domain
Clinical Operations
Topics
Healthcare

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!